Desq Long
Sign in

Company

Amneal Pharmaceuticals, Inc.

AMRX · CIK 0001723128

SEC FORM 4
$295,430.25

Amneal Pharmaceuticals, Inc. (AMRX)

Acquisition (code M) of 20,445 shares at $14.45 per share.

Reporting Person BUCHI J KEVIN · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001628280-26-061836 · filed 2026-09-14 · View filing →

SEC FORM 4
$882,000.00

Amneal Pharmaceuticals, Inc. (AMRX)

Sale of 50,000 shares at $17.64 per share.

Reporting Person Kiely John · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001628280-26-057147 · filed 2026-08-14 · View filing →

SEC FORM 4
$3,654,000.00

Amneal Pharmaceuticals, Inc. (AMRX)

Sale of 210,000 shares at $17.40 per share.

Reporting Person Daly Jason B. · Officer Title EVP, Chief Legal Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001628280-26-056754 · filed 2026-08-13 · View filing →

SEC FORM 4
$2,563,516.53

Amneal Pharmaceuticals, Inc. (AMRX)

Sale of 146,403 shares at $17.51 per share.

Reporting Person Shah Nikita · Officer Title Executive Vice President · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001628280-26-056757 · filed 2026-08-13 · View filing →

SEC FORM 4
$2,896,084.14

Amneal Pharmaceuticals, Inc. (AMRX)

Disposition (code M) of 168,573 shares at $17.18 per share.

Reporting Person BUCHI J KEVIN · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001628280-26-056752 · filed 2026-08-13 · View filing →

SEC FORM 4
$117,050.10

Amneal Pharmaceuticals, Inc. (AMRX)

Sale of 6,613 shares at $17.70 per share.

Reporting Person Daly Jason B. · Officer Title EVP, Chief Legal Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001628280-26-056754 · filed 2026-08-13 · View filing →

SEC FORM 4
—

Amneal Pharmaceuticals, Inc. (AMRX)

Acquisition (code A) of 12,763,469 shares; price not stated (see filing).

Reporting Person Patel Tushar Bhikhubhai · Transaction Code A

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0000898432-26-000655 · filed 2026-08-12 · View filing →

SEC FORM 4
—

Amneal Pharmaceuticals, Inc. (AMRX)

Acquisition (code A) of 6,381,734 shares; price not stated (see filing).

Reporting Person Patel Chirag K. · Officer Title President & Co-CEO · Transaction Code A

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001628280-26-056285 · filed 2026-08-12 · View filing →

SEC FORM 4
—

Amneal Pharmaceuticals, Inc. (AMRX)

Acquisition (code A) of 283,632 shares; price not stated (see filing).

Reporting Person Patel Gautam · Transaction Code A

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001628280-26-056288 · filed 2026-08-12 · View filing →

SEC FORM 4
—

Amneal Pharmaceuticals, Inc. (AMRX)

Acquisition (code A) of 6,381,734 shares; price not stated (see filing).

Reporting Person Patel Chintu · Officer Title Co-CEO · Transaction Code A

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001628280-26-056297 · filed 2026-08-12 · View filing →